ENTITY

Probiodrug AG (PBD NA)

Analysis

Health Care • Germany

Vivoryon Therapeutics N.V. operates as a biotechnology company. The Company offers medicines that targets post-translational modifying enzymes. Vivoryon Therapeutics focuses on Alzheimer's disease and oncology. Vivoryon Therapeutics serves patients worldwide.

Refresh

Focused

No publications yet

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00